Delivery Order SPE2DB20D2002-SPE2DB25FL53L
Award Date
7/1/25
Potential Completion Date
7/2/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TOBRADEX EYE OINTMENT 3.5GM. The contract, valued at $2,757.78, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of June 12, 2024. The award is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,683.47 Firm Fixed Price Delivery Order contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,323.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TOBRADEX EYE OINTMENT 3.5GM, a medical product used for eye care. This is a delivery order contract with a firm-fixed price pricing type, with an ultimate completion date of November 6, 2023. The contract does not have a set-aside designation, indicating open...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY6HS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.51 firm fixed-price delivery order is for the supply of TOBRADEX EYE OINTMENT 3.5GM. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,068.18 firm-fixed-price contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, a pharmaceutical product, with a performance period through August 7, 2024. This contract is not set-aside for any small business program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $2,545.89 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRADEX EYE OINTMENT 3.5GM, with a completion date of February 13, 2023. The contract type is Firm Fixed Price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOBRADEX Eye Ointment 3.5GM. The $3,547.88 firm fixed-price contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office Division, will deliver these medical supplies to support federal healthcare providers and programs. This delivery order is part of a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TOBRADEX EYE OINTMENT 3.5GM to support military healthcare programs. The $3,344.24 fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support. The contract is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of TOBRADEX EYE OINTMENT 3.5GM to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 1, 2024, with a ceiling value of $1,037.12 and a completion date of November 4, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of TOBRADEX eye ointment to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies. The contract award, valued at $3,826.33, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...